NovaBay Pharmaceuticals Inc (NBY)
0.0773
0.00 (0.00%)
USD |
NYAM |
Apr 24, 16:00
0.0751
0.00 (0.00%)
After-Hours: 06:28
NovaBay Pharmaceuticals Cash from Operations (TTM): -4.131M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -4.131M |
September 30, 2023 | -5.026M |
June 30, 2023 | -6.352M |
March 31, 2023 | -6.208M |
December 31, 2022 | -6.654M |
September 30, 2022 | -9.763M |
June 30, 2022 | -9.542M |
March 31, 2022 | -9.83M |
December 31, 2021 | -9.192M |
September 30, 2021 | -6.319M |
June 30, 2021 | -6.221M |
March 31, 2021 | -5.275M |
December 31, 2020 | -4.721M |
September 30, 2020 | -4.705M |
June 30, 2020 | -4.835M |
March 31, 2020 | -5.573M |
December 31, 2019 | -7.929M |
September 30, 2019 | -8.493M |
June 30, 2019 | -8.611M |
March 31, 2019 | -8.325M |
December 31, 2018 | -5.568M |
September 30, 2018 | -6.501M |
June 30, 2018 | -4.602M |
March 31, 2018 | -4.728M |
December 31, 2017 | -6.27M |
Date | Value |
---|---|
September 30, 2017 | -3.564M |
June 30, 2017 | -7.694M |
March 31, 2017 | -8.734M |
December 31, 2016 | -11.66M |
September 30, 2016 | -15.93M |
June 30, 2016 | -16.22M |
March 31, 2016 | -18.98M |
December 31, 2015 | -18.56M |
September 30, 2015 | -18.21M |
June 30, 2015 | -16.82M |
March 31, 2015 | -15.15M |
December 31, 2014 | -15.06M |
September 30, 2014 | -15.59M |
June 30, 2014 | -15.25M |
March 31, 2014 | -13.69M |
December 31, 2013 | -12.97M |
September 30, 2013 | -11.39M |
June 30, 2013 | -8.726M |
March 31, 2013 | -7.484M |
December 31, 2012 | -6.528M |
September 30, 2012 | -4.021M |
June 30, 2012 | -3.498M |
March 31, 2012 | -5.894M |
December 31, 2011 | -3.142M |
September 30, 2011 | -0.46M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-9.83M
Minimum
Mar 2022
-4.131M
Maximum
Dec 2023
-6.810M
Average
-6.319M
Median
Sep 2021
Cash from Operations (TTM) Benchmarks
Eyenovia Inc | -23.84M |
Palatin Technologies Inc | -26.54M |
iBio Inc | -18.89M |
Theriva Biologics Inc | -19.00M |
Oragenics Inc | -7.291M |